Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Catalent Pharma Solutions LimogesCatalent Pharma Solutions Limoges
VS
NovartisNovartis
Catalent Pharma Solutions Limoges

Catalent Pharma Solutions Limoges

48, Rue Gilles de Roberval, Limoges, 87280, FR

Last Update: 04/02/2026

View Profile
Between 750 and 799
https://www.catalent.com/
754/1000Fair

One of the very few development and manufacturing partners with the capacity and technical expertise across multiple cell types at both clinical and commercial scale. Catalent has the leadership position in the biotech industry, gene therapy offering, and delivers compr...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0
Novartis

Novartis

Novartis Campus, Basel, 4002, CH

Last Update: 20/05/2026

View Profile
Between 800 and 849
http://www.novartis.com
809/1000Good

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million pe...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:82,910
Subsidiaries:32
12-month incidents
1
Known data breaches
1
Attack type number
2

Compliance Ranges Comparison

Based On Specific Ai Models Category
Catalent Pharma Solutions Limoges

Catalent Pharma Solutions Limoges

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Novartis

Novartis

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Catalent Pharma Solutions Limoges in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Novartis has 8.26% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - Catalent Pharma Solutions Limoges (X = Date, Y = Severity)

Catalent Pharma Solutions Limoges cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Novartis (X = Date, Y = Severity)

Novartis cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Catalent Pharma Solutions Limoges

Catalent Pharma Solutions Limoges

Incidents
No explicit notable incidents reported.
Novartis

Novartis

Incidents
🔒 Incident : Breach
NOV1774449180
🔒 Incident : Cyber Attack
NOV21267722

FAQ

Between Catalent Pharma Solutions Limoges company and Novartis company, which one has the best AI Cybersecurity Score ?
Between Catalent Pharma Solutions Limoges company and Novartis company, which one has experienced more cyber incidents in the past ?
Between Catalent Pharma Solutions Limoges company and Novartis company, which one has experienced more cyber incidents this year ?
Between Catalent Pharma Solutions Limoges company and Novartis company, which one has experienced at least one ransomware attack ?
Between Catalent Pharma Solutions Limoges company and Novartis company, which one has experienced at least one data breach ?
Between Catalent Pharma Solutions Limoges company and Novartis company, which one has experienced at least one targeted cyberattack ?
Between Catalent Pharma Solutions Limoges company and Novartis company, which one has experienced at least one vulnerability ?
Between Catalent Pharma Solutions Limoges company and Novartis company, which one holds the most compliance certifications ?
Between Catalent Pharma Solutions Limoges company and Novartis company, which one holds the fewest compliance certifications ?
Between Catalent Pharma Solutions Limoges company and Novartis company, which one has the most subsidiaries ?
Between Catalent Pharma Solutions Limoges company and Novartis company, which one has the largest number of employees ?
Between Catalent Pharma Solutions Limoges and Novartis, which company holds both SOC 2 Type 1 certifications ?
Between Catalent Pharma Solutions Limoges and Novartis, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Catalent Pharma Solutions Limoges or Novartis ?
Which company is PCI DSS compliant - Catalent Pharma Solutions Limoges or Novartis ?
Between Catalent Pharma Solutions Limoges and Novartis, which company complies with HIPAA regulations for healthcare data ?
Between Catalent Pharma Solutions Limoges and Novartis, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-26422
SUMMARY

clash-verge-service-ipc before 2.3.0 has a world-reachable IPC endpoint, leading to local privilege escalation.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 8.4)
CVSS3
Base Score: 8.4
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.5
CVE-2026-11441
SUMMARY

A vulnerability was identified in theonedev onedev up to 15.0.5. This vulnerability affects the function canAccessIssue of the file /issues/ of the component Pull Request Handler. Such manipulation of the argument issue leads to improper authorization. It is possible to launch the attack remotely. Upgrading to version 15.0.6 is able to resolve this issue. It is advisable to upgrade the affected component.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11440
SUMMARY

A vulnerability was determined in theonedev onedev up to 15.0.5. This affects an unknown part of the file /repositories/{projectId}/default-branch of the component REST API. This manipulation of the argument project.defaultBranch causes improper authorization. It is possible to initiate the attack remotely. Upgrading to version 15.0.6 is able to mitigate this issue. Upgrading the affected component is advised.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11439
SUMMARY

A vulnerability was found in theonedev onedev up to 15.0.5. Affected by this issue is some unknown functionality of the file /projects/ of the component Parent Project Handler. The manipulation of the argument project.parentId results in improper authorization. The attack may be performed from remote. Upgrading to version 15.0.6 can resolve this issue. It is recommended to upgrade the affected component.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11438
SUMMARY

A vulnerability has been found in theonedev onedev up to 15.0.5. Affected by this vulnerability is an unknown functionality of the file /projects. The manipulation of the argument project.forkedFromId leads to improper authorization. The attack is possible to be carried out remotely. Upgrading to version 15.0.6 addresses this issue. Upgrading the affected component is recommended.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8